New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-glycoproteome
Frania J. Zuniga-BanuelosiD, Marcus HoffmanniD, Udo ReichliD, Erdmann RappiD
Abstract
To understand implications of protein glycosylation for clinical diagnostic and biopharmaceuticals, innovative glycoproteomic technologies are required. Recently, significant advances were made, particularly toward structure-focused N-glyco-proteomic analyses. The mass spectrometric analysis of intact N-glycopeptides using stepped collision fragmentation along with glycan oxonium ion profiling now enables to reliably discriminate between different N-glycan structures. Still, there are weaknesses that current N-glycoproteomic approaches must overcome: 1) handling of incorrect identifications, 2) identification of rare and modified N-glycans, and 3) insufficient glycoproteomic coverage, especially in complex samples. To address these shortcomings, we have developed an innovative N-glycoproteomic workflow that aims at providing comprehensive site-specific and structural N-glycoproteomic data on human blood plasma glycoproteins. The workflow features protein depletion plus various fractionation strategies and the use of high-resolution mass spectrometry with stepped collision fragmentation. Furthermore, by including a decision tree procedure established for data validation, we could significantly improve the description of the N-glycan micro-heterogeneity. Our data analysis workflow allows the reliable differentiation of ambiguous N-glycan structures like antenna-versus core-fucosylation plus the modified and rare N-glycans such as sulfated and glucuronidated ones. With this workflow, we were able to advance in the analysis of human blood plasma glycoproteins to concentrations as low as 10 pg/mL. A total of 1,929 N-glycopeptides and 942 N-glycosites derived from 805 human middle-to low-abundant glycoproteins were identified. Overall, the presented workflow holds great potential to improve our understanding of protein glycosylation and to foster the discovery of blood plasma biomarkers. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/562384v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1548a6eorg.highwire.dtl.DTLVardef@14c74dcorg.highwire.dtl.DTLVardef@8c2377org.highwire.dtl.DTLVardef@6c6845_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities
Hans J. C. T. Wessels, Purva Kulkarni, … Dirk J. Lefeber·Journal of Advanced ResearchPeer-reviewed·Sep 6, 2023
- GlypNirO: An automated workflow for quantitative N- and O-linked glycoproteomic data analysis
Toan K. Phung, Cassandra L. Pegg, Benjamin Luke Schulz·Beilstein Journal of Organic ChemistryPeer-reviewed·Sep 1, 2020
- Identification and comparison of N-glycome profiles from common dietary protein ingredients
Matthew J. Bolino, İzzet Avcı, … Steven Alex. Frese·Food Chemistry XPeer-reviewed·Nov 20, 2024
- GPMAW Glyco-Search: An Integrated Workflow for Identification and Validation of Intact Sialylated N-Glycopeptides
Maria Kyung-Ah Petersen, Simon Ngao Mule, … Martin R. Larsen·bioRxiv·Aug 6, 2026
- OxoScan-MS: Oxonium ion scanning mass spectrometry facilitates plasma glycoproteomics in large scale
Matthew E. H. White, D. Marc Jones, … Markus Ralser·bioRxiv·Jun 1, 2022
- Expanding N-Glycopeptide Identifications by Fragmentation Prediction and Glycome Network Smoothing
Joshua Klein, Luis Eduardo Carvalho, Joseph Zaia·bioRxiv·Feb 14, 2021